Key result
Combining low HDL-C, high hsCRP, and elevated Lp(a) linked to ~3.7-fold higher major cardiovascular events risk.
Why the study?
This study evaluated the association between routine lipid profile, high-sensitivity C-reactive protein, and lipoprotein(a) and incident MACE in an Asian cohort.
Does simultaneous assessment of routine lipid profile, high-sensitivity C-reactive protein, and lipoprotein(a) improve long-term risk stratification for major adverse cardiovascular events in community-dwelling Hong Kong Chinese adults without prior MACE?
Cohort (n=1,282)
Does simultaneous assessment of routine lipid profile, high-sensitivity C-reactive protein, and lipoprotein(a) improve long-term risk stratification for major adverse cardiovascular events in community-dwelling Hong Kong Chinese adults without prior MACE?
In an Asian community cohort followed for nearly 20 years, simultaneous measurement of hsCRP, lipoprotein(a), and routine lipids provided additive long-term MACE risk stratification beyond traditional risk factors.
Answers are grounded in this paper and cite their sources.
Low HDL-cholesterol was associated with incident MACE over two decades; leaves open incremental value for risk stratification in Asian cohorts.
Background We evaluated the association between the three biomarkers—routine lipid profile, high-sensitivity CRP (hsCRP) and lipoprotein(a)—and incident major adverse cardiovascular events (MACE) in an Asian cohort. Methods This analysis included community-dwelling Hong Kong Chinese individuals recruited in 2000–2004 who had concomitant measurements of lipoprotein(a), hsCRP and lipid profile. Participants were followed up from the measurement to MACE, death or 31 December 2024, whichever earlier. MACE was a composite of myocardial infarction, stroke and cardiovascular mortality. Multivariable Cox regression analysis was used to identify independent association of lipoprotein(a), hsCRP and lipid profile parameters with incident MACE, with model selection using LASSO. Associations between increasing number of abnormal biomarkers at baseline with incident MACE were examined. Findings 1282 participants without prior MACE were included. Upon median follow-up of 19.6 years, 209 participants experienced MACE (incidence: 8.33 per 1000 person-years). Low HDL-cholesterol (adjusted HR [aHR] = 1.55, 95% CI 1.13–2.12, p=0.006), hsCRP ≥ 2.0 mg/L (aHR = 1.83, 95% CI 1.30–2.56, p=0.001) and lipoprotein(a) ≥50 mg/dL (aHR = 1.49, 95% CI 1.01–2.19, p=0.042) independently predicted incident MACE, in addition to age, hypertension, diabetes, and history of cardiovascular disease. Increasing number of abnormal biomarker levels (low HDL-cholesterol, hsCRP ≥ 2.0 mg/L and lipoprotein(a) ≥50 mg/dL) was associated with increasing risk of incident MACE (1 abnormality, aHR 1.63 [95% CI 1.19–2.22, p=0.023]; 2 abnormalities: aHR 2.75 [95% CI 1.76–4.28, p < 0.001]; 3 abnormalities: aHR 3.70 [95% CI 1.32–10.3, p=0.013]). Interpretation In an Asian community-based cohort with 20-year follow-up, simultaneous measurements of lipid profile, hsCRP and lipoprotein(a) offered additional cardiovascular risk stratification, supporting the value of measuring hsCRP and lipoprotein(a) in addition to routine lipid profile in clinical practice. Funding Health and Medical Research Fund (HSRF 1994 awarded to EJ; HMRF/HSRF 1997, 2000, 2008 awarded to KSLL); Research Grants Council (GRF 7290/97M, 7426/03M, 7404/04M, 7609/05M, 7590/06M, 7626/07M, 7672/08M, 7694/10M awarded to KSLL; GRF 7229/01M awarded to BMYC; CRF HKU3/CRF/9 and HKU2/CRF/12R awarded to KSLL; AoE/M-707/18 awarded to AX; Theme-based research T12/705/17 awarded to HFT).
No takes yet. Share an insight, caveat, or question.
Lui et al. (2026) conducted a cohort in Cardiovascular risk / Major adverse cardiovascular events (MACE) (n=1,282). Triple biomarker abnormalities (low HDL-cholesterol, hsCRP >=2.0 mg/L, lipoprotein(a) >=50 mg/dL) vs. No abnormal biomarker levels was evaluated on Major adverse cardiovascular events (MACE: composite of myocardial infarction, stroke, and cardiovascular mortality) (aHR 3.70, 95% CI 1.32-10.3, p=0.013). Abnormal levels of low HDL-C, hsCRP >=/L, and Lp(a) >=/dL independently predicted major cardiovascular events, with 3 abnormalities conferring an aHR of 3.70.
Synapse has enriched 10 related papers. Consider them for comparative context: